Recurrence of primary disease in children after renal for transplantation: An evidence-based update

Pediatric Transplantation

Volumn 8, Issue 2, 2004, Pages 113-119

  Seikaly, Mouin G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Glomerulonephritis; Hemolytic uremic syndrome; Henoch Schonlein purpura; Kidney; Oxalosis; Recurrence; Transplant

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; TACROLIMUS;

ANAPHYLACTOID PURPURA; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL NEPHROTIC SYNDROME; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; METABOLIC DISORDER; OXALOSIS; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PROTEINURIA; RECURRENT DISEASE; REMISSION; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

CHILD; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 1942519328     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-3046.2003.00151.x     Document Type: Review

References (65)

1. BENFIELD MR, MCDONALD R, SULLIVAN EK et al. The 1997 annual renal transplantation in children report of the North American pediatric renal transplant cooperative study. Pediatr Transplant 1999: 3: 152-167,
2. HOYER JR, RAIJ L, VERNIER RL et al. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972: 2: 343-348.
3. MATTHEW TH. Recurrence of disease following renal transplantation. Am J Kidney Dis 1988: 12: 85-96.
4. BAQI N, TEJANI A. Recurrence of original disease in pediatric renal transplant. J Nephrol 1997: 10: 85-92.
5. BENCHIMOL C. Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr 2003: 15: 171-180.
6. European best practices guidelines for renal transplant (Part 2). Nephrol Dial Transplant 2002: 17(Suppl. 4): 3-6.
7. GULATI S, SHARMA AP, SHARMA RK et al. Changing trends of histopathology in childhood nephrotic syndrome. Am J Kid Dis 1999: 34: 646-650.
8. SHARMA M, SHARMA R, MCCARTHY ET et al. The FSGS enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999: 10: 552-561.
9. SAVIN VJ, ARTERO M, SHARMA R et al. Risk of recurrence of focal segmental (FSGS) after transplantation can be assessed using an in vitro assay of serum. J Am Soc Nephrol 1993: 4: 125-129.
10. SCHNAPER HW, AUNE TM. Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J Clin Invest 1985: 76: 341-349.
11. BAUM MA, HO M, STABLEIN DM et al. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant 2002: 6: 488-492.
12. NEWSTEAD CG. Recurrent disease in renal transplant. Nephrol Dial Transplant 2003: 18: vi68-vi74.
13. KAPLAN-PAVLOVČIČ S, FERLUGA D, HVALA A et al. Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease? Transplant Proc 2002: 34: 3122-3124.
14. FIRST MR. Living-related donor transplant should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol 1995: 9: S40-S42.
15. HAYRY P, ISONIEMI H, YILMAZ S et al. Chronic allograft rejection. Immun Rev 1993: 134: 33-81.
16. MYERS BD, ROSS J, NEWTON RJ et al. Cyclosporin-associated chronic nephropathy. N Engl J Med 1984: 311: 699-705.
17. RIZZONI G, EHRICH JH, BRUNNER FP et al. Combined report on regular dialysis and transplantation of children in Europe, 1990. Nephrol Dial Transplant 1991: 6(Suppl. 4): 31-42.
18. GLASSOCK RJ, FELDMAN D, REYNOLDS FS et al. Human renal isografts; a clinical and pathological analysis. Medicine 1968: 47: 411-454.
19. KASHTAN CE, MCENERY PT, TEJANI A et al. Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1995: 9: 679-684.
20. TEJANI A, STABLEIN DH. Recurrence of focal segmental glomerulosclerosis post-transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992: 2: S258-S263.
21. VATS A, NAYAK A, ELLIS D et al. Familial nephrotic syndrome: clinical spectrum and linkage to chromosome 19q13. Kidney Int 2000: 57: 875-881.
22. BOUTE N, GRIBOUVAL O, ROSELLI S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid resistant nephrotic syndrome. Nature Genet 2000: 24: 349-354.
23. PONTICELLI C, CAMPISE M, TARANTINO A. The different patterns response plasmapheresis of recurrent focal and segmental glomerulosclerosis. Transplant Proc 2002: 34: 3069-3071.
24. SHARIATMADAR S, NOTO TA. Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation. J Clin Apheresis 2002: 17: 78-83.
25. PRADHAN M, PETRO J, PALMER J et al. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 2003: 18: 934-938.
26. COCHAT P, SCHELL M, RANCHIN B et al, Management of recurrent nephrotic syndrome after kidney transplantation in children. Clin Nephrol 1996: 46: 17-20.
27. OHTA T, KAWAGUCHI H, HATTORI M et al. Effect of pre-and postoperative plasmapheresis on post-transplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001: 71: 628-633.
28. INGULLI E, TEJANI A, Incidence, treatment and outcome of recurrent focal segmental glomerulosclerosis post-transplantation in 42 allografts in children: a single center experience. Transplantation 1991: 512: 401-405.
29. ,SALOMON R, GAGNADOUX M-F, NIAUDET P. Intravenous cyclosporin therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003: 75: 810-814.
30. MOWRY J, MARIK J, COHEN A et al. Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporin A and plasmapheresis. Transplant Proceed 1993: 25: 1345-1346.
31. HIRANO T, AKASHI T, KEIRA T et al. Clinical impact of cyclosporin cellular pharmacodynamics in minimal change nephritic syndrome. Clin Pharmacol Ther 2000: 68: 532-540.
32. HIRANO T, AKASHI T, OKA K et al. Serum cholesterol levels and kidney transplantation outcome: attenuation of cyclosporin efficacy? Transplantation 2001: 71: 659-660.
33. MARUYMA K, TOMIZAWA Y, SEKI Y et al. Inhibition of vascular permeability factor production by cyclosporin in minimal change nephritic syndrome. Nephron 1992: 62: 27-30.
34. MCCAULEY J, SHAPIRO R, BRONSTER O et al. Renal transplantation under FK506 in patients with previous loss of renal function due to hemolytic uremic syndrome. Transplant Proc 1991: 23: 3068-3070.
35. KESSLER M. A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporin to tacrolimus. Transplantation 1999: 67: 641-643.
36. DANTAL J, BIGOT E, BOGERS W et al. Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephritic syndrome. N Engl J Med 1994: 330: 7-14.
37. RAAFAT R, TRAVIS L, KALIA A et al. Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 2000: 14: 189-194.
38. GAGNADOUX MF. Does antibody induction therapy with daclizumab or basiliximab increase the risk of recurrence of post-transplant focal segmental glomerulosclerosis? Pediatr Nephrol 2002: 17: 305.
39. FUJISAWA M, IIJIMA K, ISHIMURA T et al, Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 2002: 17: 165-168.
40. BROYER M, SELWOOD N, BRUNNER F. Recurrence of primary disease on kidney graft: European pediatric experience. J Am Soc Nephrol 1992: 2: S255-S257.
41. BACHMAN U, BRAVA C, AMEND W et al. The clinical course of IgA nephropathy and Henoch-Schonlein purpura following renal transplantation. Transplantation 1986: 42: 511-515.
42. CAMERON JS. Glomerulonephritis in renal transplants. Transplantation 1982: 34: 237-245.
43. GAGNADOUX MF, NIAUDET P, BROYER M. Non-immunological risk factors in pediatric renal transplantation. Pediatr Nephrol 1993: 7: 89-95.
44. CHEIGH JS, MOURADIAN J, SUSLIN M et al. Kidney transplant nephritic syndrome: relationship between allograft histopathology and natural course. Kidney Int 1980: 18: 358-365.
45. ANDRESDOTTIR MB, ASSMANN KJM, HILBRANDS LB et al. Type I membranoproliferative glomerulonephritis in a renal allograft: a recurrence induced by a cytomegalovirus infection? Am J Kid Dis 2000: 35: 1-7.
46. O'MEARA Y, GREEN A, CARMODY M et al, Recurrent glomerulonephritis in renal transplantation: fourteen years experience. Nephrol Dial Transplant 1989: 4: 730-734.
47. QUAN A, SULLIVAN EK, ALEXANDER SR. Recurrence of hemolytic uremic syndrome after renal transplantation in children. Transplantation 2001: 72: 742-774.
48. LOIRAT C, NIAUDET P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 2003: 18: 1095-1101.
49. VAN BUREN D, VAN BUREN CT, FLECHNER SM et al. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 1985: 98: 54-62.
50. PIOVESAN E, CASTILHOS C, POZZA R et al, Hemolytic uremic syndrome after kidney transplantation. Transplant Proc 2002: 34: 2779-2780,
51. Advisory Committee to the Renal Transplant Registry. Renal transplantation in congenital and metabolic diseases. A report from the ASC/NIH renal transplant registry. JAMA 1975: 232: 148-153.
52. FRIES JF, POWERS R, KEMPIM RL. Late stage lupus nephropathy. J Rheumatol 1974: 1: 166-175.
53. GINZLER EM, BOLLET AJ, FREIDMAN EA. The natural history and therapy of lupus nephritis. Ann Rev Med 1980: 31: 463-487.
54. GORAL S, YNARES C, SHAPPELL SB et al. Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation 2003: 75: 651-656,
55. HASEGAWA A, KAWAMURA T, ITO H et al. Fate of renal grafts with recurrent Henoch-Schonlein purpura nephritis in children. Transplant Proc 1989: 21: 2130-2133.
56. HABIB R, ANTIGNAC C, HINGLAIS N et al. Glomerular lesion in the transplanted kidney in children. Am J Kidney Dis 1987: 10: 198-207.
57. MEULDERS Q, PIRSON Y, COSYNS JP et al. Course of Henoch-Schonlein nephritis after renal transplantation. Transplantation 1994: 48: 1179-1186.
58. HOPPE B, LANGMAN CB, A United States survey on diagnosis, treatment and outcome of primary hyperoxaluria. Pediatr Nephrol 2003: 18: 986-991.
59. BARNES BA, BERGAN JJ, BRAUN WE et al. Renal transplantation in congenital and metabolic diseases. JAMA 1975: 232: 148-153.
60. ELLIS SR, HULTON SA, MCKIERNAN PJ et al, Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children. Nephrol Dial Transplant 2001: 16: 348-354.
61. GAGNADOUX MF, LACAILLE F, NIAUDET P et al. Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 2001: 16: 946-950.
62. KATZ A, KIM Y, SCHEINMAN J et al. Long-term outcome of kidney transplantation in children with oxalosis. Transplant Proc 1989: 21: 2033-2035.
63. MCDONALD JC, LANDRENEAU MD, ROHR MS et al. Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Med 1989: 321: 1100-1103.
64. DE-PAuw L, GELIN M, DANPURE CJ et al. Combined liver transplantation in primary hyperoxaluria type I. Transplantation 1990: 50: 886-887.
65. CIBRIK DM, KAPLAN B, ARNDORFER J et al. Renal allograft survival in patients with oxalosis. Transplantation 2002: 74: 707-710.